ARYA Sciences Acquisition Corp V (Nasdaq: ARYE) is a blank-check company sponsored by ARYA Sciences Holdings V LLC, an affiliate of Perceptive Advisors, a life sciences-focused investment firm. The vehicle completed its initial public offering in 2021, targeting acquisition opportunities in the life sciences and biopharmaceutical sectors. As of its Form 10-Q filed with the SEC on May 12, 2022, the company had not yet identified a definitive business combination target and remained in active search. ARYE is the fifth SPAC launched under the ARYA Sciences banner, continuing a track record of pursuing innovative healthcare and biotechnology companies. For complete filing history, timeline data, and deal analytics on ARYE, sign up for full access at SpacDesk.